title: New proofs concerning benefits from time-scheduled BP-lowering therapy.
abstract: High blood pressure (HBP) is one of the most important medical and social problems of the present era; she is considered not only the "silent killer' but also the most important reversible risk factor for cardio-vascular diseases (CVD). In the past two years important proofs have been published in favor of ABPM, a mandatory tool for the assessment of the nocturnal body pressure values, the most important predictor for the cardio-vascular prognosis, even more important in women than in men. The present paper is summarizing the data from the last published studies, concerning very significant and reliable proofs, in favor of the chronotherapy of HBP, the gold standard for good practice in the management of this disease.
authors.affiliation: Medical Clinic, Clinical Emergency Hospital Ilfov County, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. drhoriabalan@yahoo.com
authors.forename: H
authors.initials: H
authors.lastname: Bălan
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001683:Biological Clocks / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects*; D018660:Blood Pressure Monitoring, Ambulatory / Q000379:methods*; D002319:Cardiovascular System / Q000503:physiopathology; D002940:Circadian Rhythm / Q000187:drug effects*; D019468:Disease Management; D055870:Drug Chronotherapy; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D011379:Prognosis; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D012737:Sex Factors; D059039:Standard of Care
chemical_list: D000959:Antihypertensive Agents